Two studies published in the online issue of Nature report no evidence to suggest that hematopoietic stem cells, which usually produce blood cells, can turn into heart cells after injection into the heart. These studies raise a cautionary note for interpreting the results of ongoing clinical studies in which hematopoietic stem cells are injected into the heart after a heart attack.
Loren Field, Ph.D., professor of medicine and of pediatrics at the Indiana University School of Medicine and senior author of one of the Nature papers says "these studies demonstrate that the stem cells tested do not form new heart muscle when injected into damaged organs. This suggests that the functional benefit seen in clinical trials may arise from other mechanisms (for example increased blood vessel formation), and raises the possibility that there may be alternative and perhaps more efficacious ways to accomplish this."
Both research teams injected bone-marrow-derived hematopoetic stem cells into the damaged hearts of living mice and used marker proteins to monitor the injected cells. They report that although some of the transplanted cells appeared to survive, they did not appear to differentiate into new heart muscle cells. Instead they matured into cells of the traditional blood lineage.
Cindy Fox Aisen | EurekAlert!
Molecular microscopy illuminates molecular motor motion
26.07.2017 | Penn State
New virus discovered in migratory bird in Rio Grande do Sul, Brazil
26.07.2017 | Fundação de Amparo à Pesquisa do Estado de São Paulo
26.07.2017 | Event News
21.07.2017 | Event News
19.07.2017 | Event News
26.07.2017 | Physics and Astronomy
26.07.2017 | Life Sciences
26.07.2017 | Earth Sciences